Home > Insights > Blogs > Tracking Cannabis > "DEA"

Tracking Cannabis

Tracking Cannabis

(By accessing, browsing or using the pages below, you agree to the Blog Conditions of Use/Disclaimer available under "Links.")

Posts

CBD drugs moved to Schedule 5; no promises for cannabis

October 1, 2018
Marijuana and cannabis oil

The DEA has moved CBD prescription drugs with THC levels below .01% to a Schedule 5 drug after the FDA’s approval of Epidolex. However, despite the reschedule, cannabis still remains a Schedule 1 substance. READ MORE

Hazy outlook for legislation protecting medical cannabis

Michael Rosenblum October 18, 2017
cannabis leaf drawn on chalkboard

The fate of crucial federal legislation protecting medical cannabis producers, retailers and consumers from prosecution by the U.S. Department of Justice has recently become uncertain due to differences in House and Senate spending legislation. READ MORE

DEA awards Schedule II classification to synthetic THC drug

Kevin Young April 4, 2017
cannabis perscription

The DEA has applied a stricter scheduling classification to a new cannabis-containing drug than a similar drug already on the market. What can be read into this decision and how will it affect the future development of cannabis pharmaceuticals? READ MORE

The silver lining in the DEA’s refusal to reclassify cannabis

August 15, 2016
medical-cannabis---illinois_15650378689_o

Although the DEA announced last week that it would not reschedule cannabis, the decision did come with promising news of enhanced research opportunities that could bolster the cannabis industry's long-term growth. READ MORE

Thompson Coburn advises clients on state laws governing the business of cannabis to facilitate compliance with those state laws. Federal laws concerning cannabis currently conflict with state laws in states that have legalized cannabis or possession of cannabis. Although federal enforcement policy may at times defer to these states’ laws and not enforce conflicting federal laws, interested businesses and individuals should be aware that compliance with state law in no way assures compliance with federal law, and there is a risk that conflicting federal laws may be enforced in the future. In addition to this Cannabis-specific note, readers should review Thompson Coburn’s Conditions of Use / Disclaimers page containing other important information.